Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy

Nature Genetics

Volumn 20, Issue 1, 1998, Pages 96-98

  Rust, Stephan ^a   Walter, Michael ^a   Funke, Harald ^a   Von Eckardstein, Arnold ^a   Cullen, Paul ^a   Kroes, Hester Y ^b   Hordijk, Roel ^b   Geisel, Jürgen ^c   Kastelein, John ^d   Molhuizen, Henri O F ^d   Schreiner, Michaela ^a   Mischke, Anja ^a   Hahmann, Harry W ^e   Assmann, Gerd ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c SAARLAND UNIVERSITY   (Germany)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Klinik Schwabenland   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 9Q; GENETIC LINKAGE; HEART INFARCTION; ISCHEMIC HEART DISEASE; PEDIGREE ANALYSIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; TANGIER DISEASE;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CONSANGUINITY; FEMALE; HOMOZYGOTE; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MODELS, GENETIC; PEDIGREE; SEQUENCE TAGGED SITES; TANGIER DISEASE;

EID: 17344368404     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/1770     Document Type: Article

References (25)

1. Miller, N.E., Thelle, D.S., Forde, O.H. & Mjos, O.D. The Tromsö heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet 1, 965-968 (1977).
2. Gordon, T., Kannel, W.B., Castelli, W.P. & Dawber, T.R. Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch. Intern. Med. 141, 1128-1131 (1981).
3. Assmann, G. & Schulte, H. PROCAM-trial. (Panscientia Verlag, Hedingen, Zürich, 1986).
4. Fredrickson, D.S., Altrocchi, P.H., Avioli, L.V., Goodman, D.S. & Goodman, H.C. Tangier disease: Combined clinical staff conference at the National Institute of Health. Ann. Intern. Med. 55, 1016-1031 (1961).
5. Serfaty-Lacrosniere, C. et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 107, 85-98 (1994)
6. Assmann, G., von-Eckardstein, A. & Brewer, H.B. Jr. Familial high density lipoprotein deficiency: Tangier Disease, in The Metabolic and Molecular Basis of Inherited Disease, (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 2053-2072 (McGraw-Hill, New York, 1995).
7. Karathanasis, S.K., Ferris, E. & Haddad, I.A. DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc. Natl Acad. Sci. USA 84, 7198-7202 (1987).
8. Funke, H. et al. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. J. Clin. Invest. 87, 371-376 (1991).
9. Funke, H. et al. A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc. Natl Acad. Sci. USA 88, 4855-4859 (1991).
10. Funke, H. et al. Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease. J. Clin. Invest. 91, 677-683 (1993).
11. Walter, M., Gerdes, U., Seedorf, U. & Assmann, G. The high density lipoprotein- and apolipoprotein A-1-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem. Biophys. Res. Commun. 205, 850-856 (1994).
12. Francis, G.A., Knopp, R.H. & Oram, J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Clin. Invest. 96, 78-87 (1995).
13. Regler, G., Trumbach, B., Klima, B., Lackner, K.J. & Schmitz, G. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 15, 683-690 (1995).
14. Walter, M. et al. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J. Clin. Invest. 98, 2315-2323 (1996).
15. Assmann, G., Simantke, O., Schaefer, H.-E. & Smootz, E. Characterization of high density lipoproteins in patients heterozygous for Tangier disease. J. Clin. Invest. 60, 1025-1035 (1977).
16. Puffenberger, E.G. et al. Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chromosome 13q22. Hum. Mol. Genet. 3, 1217-1225 (1994).
17. Houwen, R.H.J. et al. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nature Genet. 8, 380-386 (1994).
18. Nikali, K. et al. Random search for shared chromosomal regions in four affected individuals: the assignment of a new hereditary ataxia locus. Am. J. Hum. Genet. 56, 1088-1095 (1995).
19. Lander, E. & Kruglyak, L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genet. 11, 241-247 (1995).
20. Risch, N. A note on multiple testing procedures in linkage analysis. Am. J. Hum. Genet. 48, 1058-1064 (1995).
21. Kroes, H.Y., Tuerlings, J.H.A.M., Hordijk, R., Folkers, N.R.P. & ten Kate, L.P. Another patient with an interstitial deletion of chromosome 9: case report and a review of six cases with del(9)(q22q32). J. Med. Genet. 31, 156-158 (1994).
22. Dib, C. et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380, 152-154 (1996)
23. Lathrop, G.M., Lalouel, J.M., Julier, C. & Ott, J. Strategies for multilocus linkage analysis in humans. Proc. Natl Acad. Sci. USA 81, 3443-3446 (1984).
24. Cottingham, R.W., Jr., Idury, R.M. & Schaffer, A.A. Faster sequential genetic linkage computations. Am. J. Hum. Genet. 53, 252-263 (1993).
25. Lander, E.S. & Schork, N.J. Genetic dissection of complex traits. Science 265, 2037-2048 (1994).